公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2024 | Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial | Garon, Edward B; Lu, Shun; Goto, Yasushi; De Marchi, Pedro; Paz-Ares, Luis; Spigel, David R; Thomas, Michael; CHIH-HSIN YANG ; Ardizzoni, Andrea; Barlesi, Fabrice; Orlov, Sergey; Yoshioka, Hiroshige; Mountzios, Giannis; Khanna, Sadhvi; Bossen, Claudia; Carbini, Mariana; Turri, Sabine; Myers, Andrea; Cho, Byoung Chul | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2 | | |
2016 | Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study | Langer C.J; Gadgeel S.M; Borghaei H; Papadimitrakopoulou V.A; Patnaik A; Powell S.F; Gentzler R.D; Martins R.G; Stevenson J.P; Jalal S.I; Panwalkar A; CHIH-HSIN YANG ; Gubens M; Sequist L.V; Awad M.M; Fiore J; Ge Y; Raftopoulos H; Gandhi L; KEYNOTE-021 investigators | The Lancet Oncology | 1162 | 1066 | |
2008 | Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy | CHAO-CHI HO ; SUNG-HSIN KUO ; PEI-HSIN HUANG ; Huang H.-Y.; CHIH-HSIN YANG ; PAN-CHYR YANG | Lung Cancer | 109 | 98 | |
2021 | CD73 Is regulated by the EGFR-ERK signaling pathway in non-small cell lung cancer | Griesing S.; BIN-CHI LIAO ; CHIH-HSIN YANG | Anticancer Research | 16 | 15 | |
2023 | Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset Analysis | Soo, Ross A; Cho, Byoung Chul; Kim, Joo-Hang; Ahn, Myung-Ju; Lee, Ki Hyeong; Zimina, Anastasia; Orlov, Sergey; Bondarenko, Igor; Lee, Yun-Gyoo; Lim, Yueh Ni; Lee, Sung Sook; Lee, Kyung-Hee; Pang, Yong Kek; Fong, Chin Heng; Kang, Jin Hyoung; Lim, Chun Sen; Danchaivijitr, Pongwut; Kilickap, Saadettin; CHIH-HSIN YANG ; Arslan, Cagatay; Lee, Hana; Park, Seong Nam; Cicin, Irfan | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 1 | | |
2023 | Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey | Linardou, H; Adjei, A A; Bajpai, J; Banerjee, S; Berghoff, A S; Mathias, C Cerqueira; Choo, S P; Dent, R; Felip, E; Furness, A J S; Garassino, M C; Garralda, E; Konsoulova-Kirova, A; Letsch, A; Menzies, A M; Mukherji, D; Peters, S; Sessa, C; Tsang, J; CHIH-HSIN YANG ; Garrido, P | ESMO open | 4 | | |
2017 | Challenging the Paradigm: EGFR wild-type benefit from an EGFR inhibitor in NSCLC | Melosky B; Sheffield B.S; Tsou M.-H; Gagne S.E; Ionescu (Naus) D.N; CHIH-HSIN YANG | Cancer Treatment and Research Communications | 0 | 0 | |
2010 | Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions | YU-YUN SHAO ; Hu F.-C.; JIN-TUNG LIANG ; Chiu W.-T.; ANN-LII CHENG ; CHIH-HSIN YANG | Journal of the Formosan Medical Association | 27 | 23 | |
2023 | Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer | CHIH-HSIN YANG ; Zhou, Caicun; Jänne, Pasi A; Ramalingam, Suresh S; Kim, Tae Min; Riely, Gregory J; Spira, Alexander I; Piotrowska, Zofia; Mekhail, Tarek; Garcia Campelo, Maria Rosario; Felip, Enriqueta; Bazhenova, Lyudmila; Jin, Shu; Kaur, Manmit; Diderichsen, Paul M; Gupta, Neeraj; Bunn, Veronica; Lin, Jianchang; N Churchill, Eric; Mehta, Minal; Nguyen, Danny | Expert review of anticancer therapy | 2 | 1 | |
2020 | Checkpoint Inhibitor Combined With Tyrosine Kinase Inhibitor-the End or Beginning? | De-Rui Huang, Derek; CHIH-HSIN YANG | Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 3 | 3 | |
2017 | Checkpoint Inhibitors in Metastatic EGFR-Mutated Non-Small Cell Lung Cancer-A Meta-Analysis | Lee C.K; Man J; Lord S; Links M; Gebski V; Mok T; CHIH-HSIN YANG | Journal of Thoracic Oncology | 637 | | |
2010 | Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors | CHIA-CHI LIN ; Hsu H.-H.; Sun C.-T.; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; CHIH-HSIN YANG ; Mok T. | Journal of Thoracic Oncology | 26 | 22 | |
2014 | Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers | HSIANG-FONG KAO ; I-CHUN CHEN ; CHIUN HSU ; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN ; Hu F.-C.; CHIH-HSIN YANG ; ANN-LII CHENG ; KUN-HUEI YEH | Supportive Care in Cancer | 10 | 10 | |
2015 | Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells | Tang M.-C; Wu M.-Y; Hwang M.-H; Chang Y.-T; Huang H.-J; Lin A.M.-Y; CHIH-HSIN YANG | PLoS ONE | 47 | 41 | |
2021 | Circulating exosomal integrin β3 is associated with intracranial failure and survival in lung cancer patients receiving cranial irradiation for brain metastases: A prospective observational study | Chen, Guann Yiing; CHIA-HSIEN CHENG ; YA-FANG CHEN ; CHIH-HSIN YANG ; Feng-Ming Hsu | Cancers | 10 | 8 | |
2015 | Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6 | CHIH-HSIN YANG ; Sequist L.V.; Geater S.L.; Tsai C.-M.; Mok T.S.K.; Schuler M.; Yamamoto N.; CHONG-JEN YU ; Ou S.H.I.; Zhou C.; Massey D.; Zazulina V.; Wu Y.-L. | The Lancet Oncology | 778 | 644 | |
2018 | Clinical activity of ASP8273 in Asian patients with non-small-cell lung cancer with EGFR activating and T790M mutations | Murakami H; Nokihara H; Hayashi H; Seto T; Park K; Azuma K; Tsai C.-M; CHIH-HSIN YANG ; Nishio M; Kim S.-W; Kiura K; Inoue A; Takeda K; Kang J.-H; Nakagawa T; Takeda K; Akazawa R; Kaneko Y; Shimazaki M; Morita S; Fukuoka M; Nakagawa K. | Cancer Science | 12 | 10 | |
2018 | Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non-small cell lung carcinoma: A systematic review and meta-analysis | Lee C.K; Man J; Lord S; Cooper W; Links M; Gebski V; Herbst R.S; Gralla R.J; Mok T; CHIH-HSIN YANG | JAMA Oncology | 409 | 281 | |
2015 | Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion | TZU-HSIU TSAI ; SHANG-GIN WU ; MIN-SHU HSIEH ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | Lung Cancer | 42 | 38 | |
2011 | Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach | Salto-Tellez M.; Tsao M.-S.; JIN-YUAN SHIH ; Thongprasert S.; Lu S.; Chang G.-C.; Au J.S.-K.; Chou T.-Y.; Lee J.-S.; Shi Y.-K.; Radzi A.; Kang J.-H.; Kim S.-W.; Tan S.-Y.; CHIH-HSIN YANG | Journal of Thoracic Oncology | 35 | 36 | |